These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 19068112)

  • 1. Resolution of cast nephropathy following free light chain removal by haemodialysis in a patient with multiple myeloma: a case report.
    Basnayake K; Hutchison C; Kamel D; Sheaff M; Ashman N; Cook M; Oakervee H; Bradwell A; Cockwell P
    J Med Case Rep; 2008 Dec; 2():380. PubMed ID: 19068112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined proximal tubulopathy, crystal-storing histiocytosis, and cast nephropathy in a patient with light chain multiple myeloma.
    Wu CK; Yang AH; Lai HC; Lin BS
    BMC Nephrol; 2017 May; 18(1):170. PubMed ID: 28545410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.
    Finkel KW; Cohen EP; Shirali A; Abudayyeh A;
    Clin J Am Soc Nephrol; 2016 Dec; 11(12):2273-2279. PubMed ID: 27526708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment by long haemodialysis sessions with high cut-off filters in myeloma cast nephropathy: our experience.
    Borrego-Hinojosa J; Pérez-del Barrio MP; Biechy-Baldan Mdel M; Merino-García E; Sánchez-Perales MC; García-Cortés MJ; Ocaña-Pérez E; Gutiérrez-Rivas P; Liébana-Cañada A
    Nefrologia; 2013; 33(4):515-23. PubMed ID: 23897183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trial.
    Hutchison CA; Cook M; Heyne N; Weisel K; Billingham L; Bradwell A; Cockwell P
    Trials; 2008 Sep; 9():55. PubMed ID: 18822172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haemodialysis using high cut-off dialysers for treating acute renal failure in multiple myeloma.
    Martín-Reyes G; Toledo-Rojas R; Torres-de Rueda Á; Sola-Moyano E; Blanca-Martos L; Fuentes-Sánchez L; Martínez-Esteban MD; Díez-de los Ríos MJ; Bailén-García A; González-Molina M; García-González I
    Nefrologia; 2012; 32(1):35-43. PubMed ID: 22294003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Myeloma cast nephropathy with diffuse amyloid casts without systemic amyloidosis: two cases report.
    Yong ZH; Yu XJ; Lin ZS; Zhou FD; Cen XN; Wang SX; Zhao MH
    BMC Nephrol; 2021 Jan; 22(1):6. PubMed ID: 33407225
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of acute kidney injury in symptomatic multiple myeloma.
    Bridoux F; Leung N; Belmouaz M; Royal V; Ronco P; Nasr SH; Fermand JP;
    Kidney Int; 2021 Mar; 99(3):570-580. PubMed ID: 33440212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid Deterioration of the Renal Function Caused by the Coexistence of Intratubular Amyloidosis and Myeloma Cast Nephropathy.
    Kato H; Fujigaki Y; Asakawa S; Yamaguchi Y; Uozaki H; Komatsuda A; Nagata M; Uchida S
    Intern Med; 2015; 54(23):3023-8. PubMed ID: 26631886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cast nephropathy with acute renal failure treated with high cut-off haemodialysis in a patient with multiple myeloma.
    Shum HP; Chan KC; Chow CC; Kho BC; Yan WW
    Hong Kong Med J; 2010 Dec; 16(6):489-92. PubMed ID: 21135429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management options for cast nephropathy in multiple myeloma.
    Cockwell P; Hutchison CA
    Curr Opin Nephrol Hypertens; 2010 Nov; 19(6):550-5. PubMed ID: 20827195
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Light Chain Cast Nephropathy in Multiple Myeloma: Prevalence, Impact and Management Challenges.
    Menè P; Stoppacciaro A; Lai S; Festuccia F
    Int J Nephrol Renovasc Dis; 2022; 15():173-183. PubMed ID: 35592304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of bortezomib-based chemotherapy and extracorporeal free light chain removal for treating cast nephropathy in multiple myeloma.
    Bachmann U; Schindler R; Storr M; Kahl A; Joerres A; Sturm I
    NDT Plus; 2008 Apr; 1(2):106-108. PubMed ID: 28657037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement of cast nephropathy with plasma exchange depends on the diagnosis and on reduction of serum free light chains.
    Leung N; Gertz MA; Zeldenrust SR; Rajkumar SV; Dispenzieri A; Fervenza FC; Kumar S; Lacy MQ; Lust JA; Greipp PR; Witzig TE; Hayman SR; Russell SJ; Kyle RA; Winters JL
    Kidney Int; 2008 Jun; 73(11):1282-8. PubMed ID: 18385667
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two kinds of rare light chain cast nephropathy caused by multiple myeloma: case reports and literature review.
    Sun LJ; Dong HR; Xu XY; Wang GQ; Cheng H; Chen YP
    BMC Nephrol; 2021 Jan; 22(1):42. PubMed ID: 33509125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystals, crystals everywhere but not a clue till late… Light chain crystalline proximal tubulopathy with concomitant myeloma cast nephropathy.
    Matthai SM; Alexander S; Jacob S; Duhli N; David VG; Varughese S
    Indian J Pathol Microbiol; 2020; 63(3):463-466. PubMed ID: 32769341
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of kidney biopsy in myeloma cast nephropathy: a retrospective study of 70 patients.
    Ecotière L; Thierry A; Debiais-Delpech C; Chevret S; Javaugue V; Desport E; Belmouaz S; Quellard N; Kaaki S; Goujon JM; Fermand JP; Touchard G; Bridoux F
    Nephrol Dial Transplant; 2016 Jan; 31(1):64-72. PubMed ID: 26289418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of Haemodiafiltration with Heat Sterilized High-Flux Polyphenylene HF Dialyzer in Reducing Free Light Chains in Patients with Myeloma Cast Nephropathy.
    Rousseau-Gagnon M; Agharazii M; De Serres SA; Desmeules S
    PLoS One; 2015; 10(10):e0140463. PubMed ID: 26466100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of high cut-off dialysis for acute kidney injury secondary to cast nephropathy in patients with multiple myeloma: a systematic review and meta-analysis.
    Tarragón B; Ye N; Gallagher M; Sen S; Portolés JM; Wang AY
    Clin Kidney J; 2021 Aug; 14(8):1894-1900. PubMed ID: 34345412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Light Chain Cast Nephropathy: Practical Considerations in the Management of Myeloma Kidney-What We Know and What the Future May Hold.
    Manohar S; Nasr SH; Leung N
    Curr Hematol Malig Rep; 2018 Jun; 13(3):220-226. PubMed ID: 29725932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.